Filing Flows › Embecta (EMBC) › R&D spending
Embecta (EMBC) R&D spending by quarter
Embecta's R&D spending was $5.6M in Q3 FY26 (third quarter fiscal 2026), +4% from Q2 FY26. Over the last 6 quarters it ranged from $4.4M (Q3 FY25) to $19.8M (Q4 FY24).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $5.6M | +4% | +27% |
| Q2 FY26 | $5.4M | +17% | -32% |
| Q4 FY25 | $4.6M | +5% | -77% |
| Q3 FY25 | $4.4M | -45% | — |
| Q2 FY25 | $8.0M | -60% | — |
| Q4 FY24 | $19.8M | — | — |
Q3 FY26 at a glance
Embecta, Q3 FY26: revenue $272M (-8% year over year), operating margin 17.9%, net earnings $21.1M, operating cash flow $41.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Embecta's R&D spending?
Embecta's R&D spending was $5.6M in Q3 FY26 (third quarter fiscal 2026), +4% from Q2 FY26.
How has Embecta's R&D spending changed?
Over the last 6 quarters it ranged from $4.4M (Q3 FY25) to $19.8M (Q4 FY24).